Biomarkers of response to TNF inhibition in RA
- 16 June 2015
- journal article
- research article
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 11 (8) , 446-448
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- A genome-wide association study identifies a new locus associated with the response to anti-TNF therapy in rheumatoid arthritisThe Pharmacogenomics Journal, 2015
- Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritisThe Pharmacogenomics Journal, 2015
- GWAS Replication Study Confirms the Association of PDE3A–SLCO1C1 with anti-TNF Therapy Response in Rheumatoid ArthritisPharmacogenomics, 2013
- Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid ArthritisPLOS Genetics, 2013
- Rheumatoid arthritis risk allele PTPRC is also associated with response to anti–tumor necrosis factor α therapyArthritis & Rheumatism, 2010
- Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2009
- Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis.2008
- Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics RegisterRheumatology, 2006
- Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritisAnnals of the Rheumatic Diseases, 2003